Comparable stake leader
BlackRock, Inc.
SEC ownership of GILEAD SCIENCES, INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000882095.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
- Symbol
- GILD on Nasdaq
- SEC evidence covered
- 13F and 13D/G
- Largest SEC-reported holder
- BlackRock, Inc.
- Latest 13D/G holder
- BlackRock, Inc.
- Latest parsed evidence date
- 31 Mar 2026
- CIK
- 0000882095
- Location
- Foster City, CA
Ownership snapshot
2 signals
Issuer
2 identity fields
Ownership snapshot
Top shareholders of GILEAD SCIENCES, INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
31 Mar 2026
13F
13D/G
Lead comparable stake: 8.2%
13D/G row: BlackRock, Inc.
Showing 1-8 of 50 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 8.2%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
BlackRock, Inc.
8.2%
VANGUARD CAPITAL MANAGEMENT LLC
7.5%
FMR LLC
5.3%
Capital World Investors
4.3%
STATE STREET CORP
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
8.2%
from 13D/G
|
$16,586,559,275
119,010,973 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
7.5%
|
$13,007,001,690
93,327,127 shares
|
$0 | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
5.3%
from 13D/G
|
$10,021,579,771
71,906,290 shares
|
— | 31 Mar 2026 |
| Capital World Investors |
13F
13D/G
Company
|
4.3%
from 13D/G
|
$5,753,020,069
41,283,933 shares
|
— | 31 Mar 2026 |
| STATE STREET CORP |
13F
Company
|
4.8%
|
$8,342,490,991
59,858,585 shares
|
— | 31 Mar 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
2.8%
|
$4,895,993,537
35,129,465 shares
|
— | 31 Mar 2026 |
| JPMORGAN CHASE & CO |
13F
Company
|
2.7%
|
$4,634,525,446
33,992,410 shares
|
— | 31 Mar 2026 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.4%
|
$4,135,590,576
29,726,052 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$77,756,274.
Buys
$0
Insiders: 0
Sells
$77,756,274
Insiders: 6
Net
-$77,756,274
Shares: -584,537
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 584,537
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 63,000 | $0 | $8,443,919 | -$8,443,919 |
| 3-6 | 0 | 309,280 | $0 | $43,935,320 | -$43,935,320 |
| 6-9 | 0 | 135,757 | $0 | $16,616,330 | -$16,616,330 |
| 9-12 | 0 | 76,500 | $0 | $8,760,705 | -$8,760,705 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 22 reporting-owner rows connected to GILEAD SCIENCES, INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
22
Largest Forms 3/4/5 holder
Daniel Patrick O'Day
Net 12M change
-$77,756,274
Latest report
15 May 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Daniel Patrick O'Day | Chairman & CEO, Director | $96,229,510 | -$46,668,299 | -33% | Mixed | 28 Apr 2026 |
| Andrew D. Dickinson | Chief Financial Officer | $27,433,334 | -$4,196,125 | -13% | Mixed | 15 May 2026 |
| Johanna Mercier | Chief Comm & Corp Aff Officer | $21,292,322 | -$17,796,577 | -46% | Mixed | 15 May 2026 |
| Merdad Parsey | Chief Medical Officer | $13,940,850 | Mixed | 10 Dec 2024 | ||
| Deborah H. Telman | EVP, Corporate Affairs & GC | $9,143,992 | -$6,590,487 | -42% | Mixed | 12 Nov 2025 |
| Dietmar Berger | Chief Medical Officer | $8,821,036 | Mixed | 10 Mar 2026 | ||
| Olsen Per Wold | Director | $8,754,707 | Mixed | 06 May 2021 | ||
| Sandra C. Patterson | SVP, Controllership | $6,811,146 | Mixed | 10 Mar 2025 | ||
| Diane E. Wilfong | Interim Corp Controller & CAO | $5,331,349 | Mixed | 10 Sep 2025 | ||
| Brett A. Pletcher | EVP,Corp Affairs & Gen Counsel | $4,172,613 | Mixed | 10 Jun 2022 | ||
| Jacqueline K. Barton | Director | $3,791,142 | Median | 30 Apr 2026 | ||
| Richard James Whitley | Director | $3,154,008 | Mixed | 06 May 2021 | ||
| Harish Manwani | Director | $2,092,640 | Median | 30 Apr 2026 | ||
| Javier J. Rodriguez | Director | $1,862,540 | Median | 30 Apr 2026 | ||
| Anthony S. Welters | Director | $1,797,036 | Median | 30 Apr 2026 | ||
| Jeffrey A. Bluestone | Director | $1,402,898 | -$1,791,600 | -56% | Median | 30 Apr 2026 |
| Sandra Horning | Director | $1,386,226 | Mixed | 30 Apr 2026 | ||
| Ted W. Love | Director | $764,305 | Median | 30 Apr 2026 | ||
| Keeley M. Cain Wettan | EVP Gen Counsel, Legal & Comp | $754,915 | Mixed | 10 Mar 2026 | ||
| Kelly A. Kramer | Director | $170,186 | -$713,186 | -81% | Filing P/S | 30 Apr 2026 |
Recent insider transactions for GILEAD SCIENCES, INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.7% | $396,810 | $132.27 | -3,000 | 173,191 | 15 May 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -18.2% | $3,676,199 | $131.29 | -28,000 | 125,779 | 15 May 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Options Exercise | 19.4% | 25,000 | 153,779 | 15 May 2026 | Direct | ||
| Johanna Mercier | GILD | Non-qualified Stock Option (Right to Buy) | Options Exercise | -52% | -25,000 | 23,110 | 15 May 2026 | Direct | ||
| Jeffrey A. Bluestone | GILD | Common Stock | Award | 12.8% | 1,146 | 10,066 | 30 Apr 2026 | Direct | ||
| Jeffrey A. Bluestone | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Jacqueline K. Barton | GILD | Common Stock | Award | 4.4% | 1,146 | 27,202 | 30 Apr 2026 | Direct | ||
| Jacqueline K. Barton | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Sandra J. Horning | GILD | Common Stock | Award | 22.3% | 1,146 | 6,293 | 30 Apr 2026 | Direct | ||
| Sandra J. Horning | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Ted W. Love | GILD | Common Stock | Award | 26.4% | 1,146 | 5,484 | 30 Apr 2026 | Direct | ||
| Ted W. Love | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Javier J. Rodriguez | GILD | Common Stock | Award | 9.38% | 1,146 | 13,364 | 30 Apr 2026 | Direct | ||
| Javier J. Rodriguez | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Anthony Welters | GILD | Common Stock | Award | 9.75% | 1,146 | 12,894 | 30 Apr 2026 | Direct | ||
| Anthony Welters | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Harish Manwani | GILD | Common Stock | Tax liability | -1.47% | -224 | 15,015 | 30 Apr 2026 | Direct | ||
| Harish Manwani | GILD | Common Stock | Award | 8.13% | 1,146 | 15,239 | 30 Apr 2026 | Direct | ||
| Harish Manwani | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Kelly A. Kramer | GILD | Non-qualified Stock Option (Right to Buy) | Award | 4,884 | 4,884 | 30 Apr 2026 | Direct | |||
| Kelly A. Kramer | GILD | Restricted Stock Unit | Award | 6% | 1,146 | 20,256 | 30 Apr 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -1.56% | $1,291,608 | $129.16 | -10,000 | 632,567 | 28 Apr 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.67% | $422,880 | $140.96 | -3,000 | 176,191 | 15 Apr 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -2.28% | $422,880 | $140.96 | -3,000 | 128,779 | 15 Apr 2026 | Direct |
| Daniel Patrick O'Day | GILD | Common Stock | Sale | -1.53% | $1,368,162 | $136.82 | -10,000 | 642,567 | 27 Mar 2026 | Direct |
| Johanna Mercier | GILD | Common Stock | Sale | -2.23% | $432,690 | $144.23 | -3,000 | 131,779 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Sale | -1.65% | $432,690 | $144.23 | -3,000 | 179,191 | 16 Mar 2026 | Direct |
| Andrew D. Dickinson | GILD | Common Stock | Tax liability | -1.7% | -3,147 | 182,191 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Common Stock | Options Exercise | 3.62% | 6,469 | 185,338 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Non-qualified Stock Option (Right to Buy) | Award | 35,880 | 35,880 | 10 Mar 2026 | Direct | |||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Award | 45.5% | 9,590 | 30,647 | 10 Mar 2026 | Direct | ||
| Andrew D. Dickinson | GILD | Restricted Stock Unit | Options Exercise | -23.5% | -6,469 | 21,057 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Tax liability | -2.33% | -3,216 | 134,779 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Common Stock | Options Exercise | 5.04% | 6,617 | 137,995 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Non-qualified Stock Option (Right to Buy) | Award | 35,880 | 35,880 | 10 Mar 2026 | Direct | |||
| Johanna Mercier | GILD | Restricted Stock Unit | Award | 45.5% | 9,590 | 30,647 | 10 Mar 2026 | Direct | ||
| Johanna Mercier | GILD | Restricted Stock Unit | Options Exercise | -23.9% | -6,617 | 21,057 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Tax liability | -10.7% | -606 | 5,054 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Common Stock | Options Exercise | 28.2% | 1,246 | 5,660 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Non-qualified Stock Option (Right to Buy) | Award | 18,885 | 18,885 | 10 Mar 2026 | Direct | |||
| Keeley M. Cain Wettan | GILD | Restricted Stock Unit | Award | 32.5% | 5,050 | 20,586 | 10 Mar 2026 | Direct | ||
| Keeley M. Cain Wettan | GILD | Restricted Stock Unit | Options Exercise | -7.42% | -1,246 | 15,536 | 10 Mar 2026 | Direct | ||
| Erin E. Burkhart | GILD | Non-qualified Stock Option (Right to Buy) | Award | 5,455 | 5,455 | 10 Mar 2026 | Direct | |||
| Erin E. Burkhart | GILD | Restricted Stock Unit | Award | 26.5% | 2,355 | 11,245 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Tax liability | -1.47% | -9,767 | 652,567 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Common Stock | Options Exercise | 3.12% | 20,026 | 662,334 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Non-qualified Stock Option (Right to Buy) | Award | 122,755 | 122,755 | 10 Mar 2026 | Direct | |||
| Daniel Patrick O'Day | GILD | Restricted Stock Unit | Award | 48.2% | 32,815 | 100,859 | 10 Mar 2026 | Direct | ||
| Daniel Patrick O'Day | GILD | Restricted Stock Unit | Options Exercise | -22.7% | -20,026 | 68,044 | 10 Mar 2026 | Direct | ||
| Dietmar Berger | GILD | Common Stock | Tax liability | -5.3% | -1,063 | 18,982 | 10 Mar 2026 | Direct |
* marks a reported price that did not pass the local price check.